Nov 5, 8:45 AM ET
GE HealthCare said Taha Kass-Hout notified the company on November 4, 2026 that he will resign as Chief Science and Technology Officer. His last day will be December 31, 2026. The filing gives no successor name or reason for the departure.
- Taha Kass-Hout will resign as Chief Science and Technology Officer.
- He notified GE HealthCare on November 4, 2026.
- His last day at the company will be December 31, 2026.
Read the filing on SEC.gov ↗
Oct 28, 6:25 AM ET
GE HealthCare reported third quarter 2026 revenue of $5.5 billion, up 7.2%, and net income attributable to the company of $615 million versus $446 million a year earlier. The company raised its full-year 2026 adjusted EPS guidance to $4.95 to $5.05, and also disclosed that Jeannette Bankes, President and CEO of Patient Care Solutions, will resign effective November 15, 2026, with Neal Sandy succeeding her on November 16.
- Q3 2026 revenue of $5.5 billion, up 7.2% (organic growth 6.2%); diluted EPS of $1.36 versus $0.98; adjusted EPS of $1.34 versus $1.07
- Full-year 2026 adjusted EPS guidance raised to $4.95 to $5.05, from $4.80 to $5.00; organic revenue growth now about 4.0%
- Jeannette Bankes to resign as President and CEO, Patient Care Solutions, with last day November 15, 2026; Neal Sandy to become President and CEO on November 16, 2026
- Company plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expected to close in the first half of 2027
Read the filing on SEC.gov ↗
Sep 22, 4:07 PM ET
GE HealthCare appointed Pascal Desroches, Senior Executive Vice President and CFO of AT&T, as a director effective January 4, 2027, and to its Audit Committee and Talent, Culture, and Compensation Committee. The filing says he plans to retire from AT&T on December 31, 2026, and that the appointment adds finance and governance experience to the board.
- Pascal Desroches joins the GE HealthCare Board effective January 4, 2027.
- He will serve on the Audit Committee and the Talent, Culture, and Compensation Committee.
- Desroches has served as CFO of AT&T since 2021 and plans to retire from AT&T on December 31, 2026.
- He will receive non-employee director compensation and enter into an indemnification agreement with the company.
Read the filing on SEC.gov ↗
Aug 18, 9:03 AM ET
GE HealthCare appointed William K. Grogan, currently executive vice president and CFO of Xylem Inc., as Chief Financial Officer effective September 14, 2026, succeeding interim CFO George Newcomb, who will remain Controller and Chief Accounting Officer. The filing sets out his pay package, including a $900,000 base salary, a 100% target bonus, and sign-on awards to offset compensation forfeited at Xylem, which matters to shareholders as it defines the company's new top finance executive and its compensation commitments.
- Grogan, age 48, has been Xylem's EVP and CFO since October 2023 and was IDEX Corporation's CFO from January 2017 to September 2023.
- Offer letter: $900,000 base salary, target annual bonus of 100% of salary, and a 2026 annual LTI award with a $3,300,000 target grant date value.
- Sign-on payments include $550,000 in cash and a $4,000,000 RSU award, with cash repayment required if he resigns within two years.
- Newcomb ceases as interim CFO on September 14, 2026, and continues as Controller and Chief Accounting Officer.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.